STOCK TITAN

Koru Med Sys - KRMD STOCK NEWS

Welcome to our dedicated page for Koru Med Sys news (Ticker: KRMD), a resource for investors and traders seeking the latest updates and insights on Koru Med Sys stock.

Koru Medical Systems, Inc. (NASDAQ: KRMD), headquartered in Chester, New York, is a specialized developer and manufacturer of innovative medical devices designed to enhance the quality of life for patients with chronic illnesses. Operating within the healthcare and medical technology industry, the company focuses on subcutaneous infusion systems that deliver life-saving therapies efficiently and reliably. With a mission to improve patient outcomes, Koru Medical Systems has established itself as a trusted provider of mechanical infusion solutions.

Core Business and Product Ecosystem

Koru Medical Systems is best known for its flagship product line, the FREEDOM Integrated Infusion System, which includes the FREEDOM60® and FreedomEdge® Syringe Drivers. These mechanical infusion devices are designed to provide a consistent and controlled flow of medication, offering patients a portable and user-friendly alternative to traditional infusion methods. Complementing these devices are the company's proprietary consumables, such as Precision Flow Rate Tubing, which ensures accurate medication delivery, and HIgH-Flo Subcutaneous Safety Needle Sets, designed for patient comfort and safety during therapy.

These products are primarily used for subcutaneous infusion of immunoglobulin therapies, a critical treatment for chronic conditions like Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). By addressing the unique needs of these patient populations, Koru Medical Systems plays a vital role in enabling home-based care, reducing the burden on healthcare facilities, and empowering patients to manage their conditions with greater independence.

Market Position and Competitive Landscape

Koru Medical Systems operates in a niche segment of the medical device industry, focusing on mechanical subcutaneous infusion systems. This specialization allows the company to differentiate itself from competitors that primarily produce electronic infusion devices. The mechanical nature of Koru's products offers several advantages, including simplicity, reliability, and cost-effectiveness, making them particularly well-suited for home-based therapies.

The company faces competition from larger, more diversified medical device manufacturers, but its focus on a specific market segment and its comprehensive product ecosystem provide a competitive edge. By offering a range of complementary products, Koru Medical Systems fosters customer loyalty and positions itself as a one-stop solution for subcutaneous infusion needs.

Industry Significance and Value Proposition

The healthcare industry is witnessing a growing demand for home-based care solutions, driven by advancements in medical technology and a shift towards patient-centric care models. Koru Medical Systems is well-positioned to capitalize on this trend, as its products enable patients to receive critical therapies in the comfort of their homes. This not only improves patient convenience and adherence to treatment but also reduces the overall cost of care by minimizing hospital visits and associated expenses.

In addition to its patient-focused approach, Koru Medical Systems demonstrates a commitment to quality and safety, evident in its rigorous product design and manufacturing processes. The company's ability to meet stringent regulatory standards further underscores its reliability and trustworthiness as a medical device provider.

Conclusion

Koru Medical Systems, Inc. is a key player in the medical technology industry, specializing in subcutaneous infusion systems that address critical healthcare needs. Through its innovative product offerings and focus on improving patient outcomes, the company has carved out a unique position in the market. By enabling home-based care and delivering life-saving therapies, Koru Medical Systems continues to make a meaningful impact on the lives of patients and the broader healthcare ecosystem.

Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) reported third quarter net revenue of $7.0 million, a 10% decline versus the prior year. The company also updated its full year 2023 outlook, revising net revenue guidance to $28.0 to $28.5 million and reaffirming gross margin guidance between 58%-60% for the full year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
-
Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) Receives FDA Clearance for FREEDOM60® Infusion System with Hizentra® 50 mL Prefilled Syringes, Expanding Benefits of SCIg Therapy in the Home
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.19%
Tags
-
Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will participate in two upcoming investor conferences: Canaccord MedTech, Diagnostics and Digital Health & Services Forum and the 14th Annual Craig-Hallum Alpha Select Conference, both on November 16th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
conferences
Rhea-AI Summary
KORU Medical Systems will report its third quarter 2023 financial results on November 8, 2023. The company will host a conference call and webcast to discuss the results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.86%
Tags
conferences earnings
-
Rhea-AI Summary
KORU Medical Systems to present two abstracts at the Immunoglobulin National Society 2023 National Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
conferences
-
Rhea-AI Summary
KORU Medical Systems appoints Edward Wholihan to its Board of Directors, bringing over 25 years of experience as CFO in the life sciences and healthcare sectors. His insights are expected to contribute to the company's future growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
management
Rhea-AI Summary
KORU Medical Systems to participate in Gilmartin Group Emerging Growth Company Showcase on September 21, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
conferences acquisition
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.22%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags

FAQ

What is the current stock price of Koru Med Sys (KRMD)?

The current stock price of Koru Med Sys (KRMD) is $3.16 as of March 6, 2025.

What is the market cap of Koru Med Sys (KRMD)?

The market cap of Koru Med Sys (KRMD) is approximately 147.6M.

What does Koru Medical Systems specialize in?

Koru Medical Systems specializes in subcutaneous infusion systems, including mechanical syringe drivers and related consumables for chronic illness therapies.

What are the primary products of Koru Medical Systems?

The primary products include the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets.

What conditions are treated using Koru Medical's products?

Koru Medical's products are used to treat chronic conditions such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

How does Koru Medical differentiate itself from competitors?

Koru Medical focuses on mechanical infusion systems, which are portable, reliable, and cost-effective, making them ideal for home-based therapies.

Who are the primary customers of Koru Medical Systems?

The primary customers include healthcare providers, hospitals, and patients requiring regular subcutaneous infusion therapies.

What is the significance of Koru Medical's products in the healthcare industry?

Koru Medical's products enable home-based care, improving patient convenience, adherence to treatment, and reducing healthcare costs.

What is the FREEDOM Integrated Infusion System?

The FREEDOM Integrated Infusion System is a product line of mechanical syringe drivers designed for controlled and consistent subcutaneous medication delivery.

What market segment does Koru Medical Systems target?

Koru Medical targets the niche market of subcutaneous infusion devices, primarily for chronic illness management in home-based care settings.
Koru Med Sys

Nasdaq:KRMD

KRMD Rankings

KRMD Stock Data

147.60M
42.54M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MAHWAH